Analysis and Comment

More Analysis and Comment

COVID-19

Moderna just released the results of a phase 1 trial for a COVID-19 vaccine. JOSEPH PREZIOSO/AFP via Getty Images

What the phase 1 trials of the first COVID-19 vaccine really mean

Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.

More

Curious Kids

More

Gene-editing people

More

Most Read past week

  1. Coronavirus, ‘Plandemic’ and the seven traits of conspiratorial thinking
  2. Infected with the coronavirus but not showing symptoms? A physician answers 5 questions about asymptomatic COVID-19
  3. Blocking the deadly cytokine storm is a vital weapon for treating COVID-19
  4. What the phase 1 trials of the first COVID-19 vaccine really mean
  5. To safely explore the solar system and beyond, spaceships need to go faster – nuclear-powered rockets may be the answer

Pitch an idea

Got a news tip or article idea for The Conversation?

Tell us

Our Audience

The Conversation has a monthly audience of 18 million users, and reach of 42 million through Creative Commons republication.

Want to Write?

Write an article and join a growing community of more than 105,700 academics and researchers from 3,363 institutions.

Register now

Make a Donation

The Conversation relies on university, foundation and reader support. If you would like to help us have even better conversations, then you may like to make a one-off or on-going donation.

Donate